Can a standard treatment be proposed for penile cancer?
Cancers of the penis are aggressive tumours with a poor prognosis. Treatment decisions, which are poorly defined in these cases of rare cancers, should be based on multidisciplinary consultations.
Stroke risk profiles of patients detected via opportunistic and systematic screenings were similar. Data derived from the SAFE study suggest that active screening for AF in patients aged ≥65 years in primary care is a useful screening programme with 78-83% of patients identified eligible for anticoagulation treatment according to the CHADS2 criteria.